Wenjing Ruan

1.3k total citations
36 papers, 1.0k citations indexed

About

Wenjing Ruan is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Wenjing Ruan has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Cell Biology. Recurrent topics in Wenjing Ruan's work include Growth Hormone and Insulin-like Growth Factors (10 papers), Metabolism, Diabetes, and Cancer (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Wenjing Ruan is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (10 papers), Metabolism, Diabetes, and Cancer (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Wenjing Ruan collaborates with scholars based in China, Canada and United States. Wenjing Ruan's co-authors include Maode Lai, Maode Lai, Yong Rao, Peng Pang, Jianguang Zhou, Jie Lin, Kejing Ying, Yu Ma, Fangying Xu and Julie Desbarats and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and PLoS ONE.

In The Last Decade

Wenjing Ruan

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenjing Ruan China 19 611 160 150 140 129 36 1.0k
Isabelle Vilgrain France 22 940 1.5× 203 1.3× 201 1.3× 165 1.2× 122 0.9× 55 1.5k
Mateus T. Guerra United States 20 809 1.3× 238 1.5× 129 0.9× 79 0.6× 141 1.1× 32 1.4k
Hadara Rubinfeld Israel 18 780 1.3× 164 1.0× 236 1.6× 107 0.8× 109 0.8× 27 1.3k
Itsuko Nakano Japan 17 1.1k 1.8× 193 1.2× 71 0.5× 127 0.9× 101 0.8× 24 1.6k
Julien Ghislain Canada 22 663 1.1× 142 0.9× 195 1.3× 99 0.7× 325 2.5× 35 1.3k
Hideo Mogami Japan 24 937 1.5× 227 1.4× 159 1.1× 86 0.6× 332 2.6× 39 1.8k
Margaret A. Lawlor United Kingdom 8 1.3k 2.1× 150 0.9× 129 0.9× 156 1.1× 88 0.7× 10 1.6k
Heike Naumann Germany 15 800 1.3× 145 0.9× 45 0.3× 144 1.0× 177 1.4× 18 1.3k
Svetlana Earnest United States 20 1.0k 1.7× 276 1.7× 51 0.3× 96 0.7× 120 0.9× 28 1.3k
Feng Qiao United States 18 1.0k 1.7× 106 0.7× 79 0.5× 173 1.2× 89 0.7× 39 1.4k

Countries citing papers authored by Wenjing Ruan

Since Specialization
Citations

This map shows the geographic impact of Wenjing Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjing Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjing Ruan more than expected).

Fields of papers citing papers by Wenjing Ruan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjing Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjing Ruan. The network helps show where Wenjing Ruan may publish in the future.

Co-authorship network of co-authors of Wenjing Ruan

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjing Ruan. A scholar is included among the top collaborators of Wenjing Ruan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjing Ruan. Wenjing Ruan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruan, Wenjing, Jing Xu, Fan Yang, Xiaohong Wu, & Kejing Ying. (2024). Tropheryma whipplei infection in the lung of a patient with long COVID: a case report. BMC Infectious Diseases. 24(1). 292–292. 4 indexed citations
2.
Shen, Jinze, Yuchen Wu, Wenjing Ruan, Feng Zhu, & Shiwei Duan. (2022). miR-1908 Dysregulation in Human Cancers. Frontiers in Oncology. 12. 857743–857743. 16 indexed citations
3.
Xiao, Jian, et al.. (2021). Bleeding with gastrointestinal and ureteral ulcers after gefitinib treatment: a case report. Translational Cancer Research. 10(4). 1941–1946. 7 indexed citations
4.
Zhou, Yong, Hangdi Xu, Pan Zhou, et al.. (2020). Validation of novel automatic ultra-wideband radar for sleep apnea detection. Journal of Thoracic Disease. 12(4). 1286–1295. 30 indexed citations
5.
Zhou, Yong, Wenjing Ruan, Joy Q. Jin, et al.. (2019). Pulmonary vascular involvement of IgG4-related disease. Medicine. 98(6). e14437–e14437. 10 indexed citations
6.
Li, Hua, et al.. (2019). Impact of Taurine on the proliferation and apoptosis of human cervical carcinoma cells and its mechanism. Chinese Medical Journal. 132(8). 948–956. 18 indexed citations
7.
Ruan, Wenjing, et al.. (2016). Eiger-induced cell death relies on Rac1-dependent endocytosis. Cell Death and Disease. 7(4). e2181–e2181. 12 indexed citations
8.
Zhu, Shuzhen, Fangying Xu, Enbo Xu, et al.. (2015). IGFBP-rP1 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer. Cell Death and Disease. 6(3). e1695–e1695. 27 indexed citations
9.
Zhu, Shuzhen, Fangying Xu, Jing Zhang, Wenjing Ruan, & Maode Lai. (2014). Insulin-like growth factor binding protein-related protein 1 and cancer. Clinica Chimica Acta. 431. 23–32. 20 indexed citations
10.
Yang, Li, Min Lin, Wenjing Ruan, et al.. (2012). Nkx2-1: a novel tumor biomarker of lung cancer. Journal of Zhejiang University SCIENCE B. 13(11). 855–866. 28 indexed citations
11.
Ruan, Wenjing, Yinghong Wang, Yu Ma, et al.. (2010). HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma. Journal of Experimental & Clinical Cancer Research. 29(1). 41–41. 27 indexed citations
12.
Ruan, Wenjing & Kejing Ying. (2010). Abnormal expression of IGF-binding proteins, an initiating event in idiopathic pulmonary fibrosis?. Pathology - Research and Practice. 206(8). 537–543. 15 indexed citations
13.
Ruan, Wenjing & Maode Lai. (2009). Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome?. Acta Diabetologica. 47(1). 5–14. 71 indexed citations
14.
Ma, Yu, Bingjian Lü, Wenjing Ruan, et al.. (2008). Tumor suppressor gene insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) induces senescence-like growth arrest in colorectal cancer cells. Experimental and Molecular Pathology. 85(2). 141–145. 26 indexed citations
15.
Lin, Jie, et al.. (2008). Reactivation of IGFBP7 by DNA demethylation inhibits human colon cancer cell growth in vitro. Cancer Biology & Therapy. 7(12). 1896–1900. 34 indexed citations
16.
Ruan, Wenjing, Christopher T. Lee, & Julie Desbarats. (2008). A Novel Juxtamembrane Domain in Tumor Necrosis Factor Receptor Superfamily Molecules Activates Rac1 and Controls Neurite Growth. Molecular Biology of the Cell. 19(8). 3192–3202. 38 indexed citations
17.
Ruan, Wenjing, et al.. (2004). The Ste20-like kinase misshapen functions together with Bicaudal-D and dynein in driving nuclear migration in the developing drosophila eye. Mechanisms of Development. 122(1). 97–108. 32 indexed citations
20.
Ruan, Wenjing, Peng Pang, & Yong Rao. (1999). The SH2/SH3 Adaptor Protein Dock Interacts with the Ste20-like Kinase Misshapen in Controlling Growth Cone Motility. Neuron. 24(3). 595–605. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026